[SERMs: mechanisms of action and therapeutic indications].
Malville
Elodie
E
Service du Pr Kottler, CHR Clemenceau, Cannes.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000517:prevention & control; D016889:Endometrial Neoplasms / Q000139:chemically induced; D005260:Female; D006801:Humans; D009928:Organ Specificity; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control; D011960:Receptors, Estrogen / Q000187:drug effects; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D019851:Thrombophilia / Q000139:chemically induced
D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators